 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 05/22/2017 |
$65.55 |
$65.62 |
$64.80 |
$65.44 |
5.54M | | 05/23/2017 |
$65.44 |
$66.26 |
$65.43 |
$65.84 |
4.68M | | 05/24/2017 |
$65.79 |
$66.12 |
$65.57 |
$65.93 |
3.17M | | 05/25/2017 |
$66.06 |
$66.57 |
$65.80 |
$66.32 |
4.06M | | 05/26/2017 |
$66.14 |
$66.41 |
$65.85 |
$66.06 |
4.06M |
|
|
| AbbVie is a research-based biopharmaceutical company. Co.'s portfolio of products includes a line of therapies that addresses serious diseases such as: HUMIRA (adalimumab) to treat autoimmune diseases; oncology products such as IMBRUVICA (ibrutinib) and Venclexta (venetoclax); virology products such as VIEKIRA PAK for the treatment of hepatitis C and Norvir (ritonavir) for the treatment of human immunodeficiency virus-1 infection; metabolic and hormone products that target conditions such as testosterone deficiency; endocrinology products such as Lupron (leuprolide acetate) for the palliative treatment of advanced prostate cancer, treatment of endometriosis and central precocious puberty. |
|
|
AbbVie (ABBV) has the following price history information. Looking back at ABBV historical stock prices for the last five trading days, on May 22, 2017, ABBV opened at $65.55, traded as high as $65.62 and as low as $64.80, and closed at $65.44. Trading volume was a total of 5.54M shares. On May 23, 2017, ABBV opened at $65.44, traded as high as $66.26 and as low as $65.43, and closed at $65.84. Trading volume was a total of 4.68M shares. On May 24, 2017, ABBV opened at $65.79, traded as high as $66.12 and as low as $65.57, and closed at $65.93. Trading volume was a total of 3.17M shares. On May 25, 2017, ABBV opened at $66.06, traded as high as $66.57 and as low as $65.80, and closed at $66.32. Trading volume was a total of 4.06M shares. On May 26, 2017, ABBV opened at $66.14, traded as high as $66.41 and as low as $65.85, and closed at $66.06. Trading volume was a total of 4.06M shares.
ABBV Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into AbbVie shares, starting with a $10,000 purchase of ABBV, and working forward through the historical stock price information to today.
Growth of $10,000.00
With Dividends Reinvested
|
| Start date: |
01/02/2013 |
|
| End date: |
05/26/2017 |
|
| Start price/share: |
$35.12 |
|
| End price/share: |
$66.06 |
|
| Starting shares: |
284.74 |
|
| Ending shares: |
335.07 |
|
| Dividends reinvested/share: |
$8.84 |
|
| Total return: |
121.35% |
|
| Average Annual Total Return: |
19.82% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$22,135.98 |
|
| Years: |
4.39 |
|
| |
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
01/02/2013 |
|
| End date: |
05/26/2017 |
|
| Start price/share: |
$35.12 |
|
| End price/share: |
$66.06 |
|
| Dividends collected/share: |
$8.84 |
|
| Total return: |
113.27% |
|
| Average Annual Total Return: |
18.81% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$21,327.65 |
|
| Years: |
4.39 |
|
|
|
| Date |
Close |
| 05/22/2017 | $65.44 | | 05/23/2017 | $65.84 | | 05/24/2017 | $65.93 | | 05/25/2017 | $66.32 | | 05/26/2017 | $66.06 |
|
|
